Global Epilepsy Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

Epilepsy Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Epilepsy Drugs market is projected to reach US$ 5842.4 million in 2029, increasing from US$ 4769.1 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.

In terms of geography, the Americas led the global epilepsy drugs market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Abbott Laboratories
    GlaxoSmithKline Plc
    UCB
    Cephalon
    Johnson & Johnson
    Pfizer
    Novartis AG
    Abbvie
    Janssen Pharmaceuticals
    Sunovion Pharmaceuticals
    Bausch Health
    Sanofi S.A
    Takeda
    Eisai
    F. Hoffmann-La Roche

Segment by Type
    First Generation
    Second Generation

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Epilepsy Drugs market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Epilepsy Drugs introduction, etc. Epilepsy Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Epilepsy Drugs market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

 1 Market Overview of Epilepsy Drugs
    1.1 Epilepsy Drugs Market Overview
        1.1.1 Epilepsy Drugs Product Scope
        1.1.2 Epilepsy Drugs Market Status and Outlook
    1.2 Global Epilepsy Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Epilepsy Drugs Market Size by Region (2018-2029)
    1.4 Global Epilepsy Drugs Historic Market Size by Region (2018-2023)
    1.5 Global Epilepsy Drugs Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Epilepsy Drugs Market Size (2018-2029)
        1.6.1 North America Epilepsy Drugs Market Size (2018-2029)
        1.6.2 Europe Epilepsy Drugs Market Size (2018-2029)
        1.6.3 Asia-Pacific Epilepsy Drugs Market Size (2018-2029)
        1.6.4 Latin America Epilepsy Drugs Market Size (2018-2029)
        1.6.5 Middle East & Africa Epilepsy Drugs Market Size (2018-2029)

 2 Epilepsy Drugs Market by Type
    2.1 Introduction
        2.1.1 First Generation
        2.1.2 Second Generation
    2.2 Global Epilepsy Drugs Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Epilepsy Drugs Historic Market Size by Type (2018-2023)
        2.2.2 Global Epilepsy Drugs Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Epilepsy Drugs Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Epilepsy Drugs Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Epilepsy Drugs Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Epilepsy Drugs Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Epilepsy Drugs Revenue Breakdown by Type (2018-2029)

 3 Epilepsy Drugs Market Overview by Application
    3.1 Introduction
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Epilepsy Drugs Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Epilepsy Drugs Historic Market Size by Application (2018-2023)
        3.2.2 Global Epilepsy Drugs Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Epilepsy Drugs Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Epilepsy Drugs Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Epilepsy Drugs Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Epilepsy Drugs Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Epilepsy Drugs Revenue Breakdown by Application (2018-2029)

 4 Epilepsy Drugs Competition Analysis by Players
    4.1 Global Epilepsy Drugs Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2022)
    4.3 Date of Key Players Enter into Epilepsy Drugs Market
    4.4 Global Top Players Epilepsy Drugs Headquarters and Area Served
    4.5 Key Players Epilepsy Drugs Product Solution and Service
    4.6 Competitive Status
        4.6.1 Epilepsy Drugs Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Abbott Laboratories
        5.1.1 Abbott Laboratories Profile
        5.1.2 Abbott Laboratories Main Business
        5.1.3 Abbott Laboratories Epilepsy Drugs Products, Services and Solutions
        5.1.4 Abbott Laboratories Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.1.5 Abbott Laboratories Recent Developments
    5.2 GlaxoSmithKline Plc
        5.2.1 GlaxoSmithKline Plc Profile
        5.2.2 GlaxoSmithKline Plc Main Business
        5.2.3 GlaxoSmithKline Plc Epilepsy Drugs Products, Services and Solutions
        5.2.4 GlaxoSmithKline Plc Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.2.5 GlaxoSmithKline Plc Recent Developments
    5.3 UCB
        5.3.1 UCB Profile
        5.3.2 UCB Main Business
        5.3.3 UCB Epilepsy Drugs Products, Services and Solutions
        5.3.4 UCB Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.3.5 Cephalon Recent Developments
    5.4 Cephalon
        5.4.1 Cephalon Profile
        5.4.2 Cephalon Main Business
        5.4.3 Cephalon Epilepsy Drugs Products, Services and Solutions
        5.4.4 Cephalon Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.4.5 Cephalon Recent Developments
    5.5 Johnson & Johnson
        5.5.1 Johnson & Johnson Profile
        5.5.2 Johnson & Johnson Main Business
        5.5.3 Johnson & Johnson Epilepsy Drugs Products, Services and Solutions
        5.5.4 Johnson & Johnson Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.5.5 Johnson & Johnson Recent Developments
    5.6 Pfizer
        5.6.1 Pfizer Profile
        5.6.2 Pfizer Main Business
        5.6.3 Pfizer Epilepsy Drugs Products, Services and Solutions
        5.6.4 Pfizer Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.6.5 Pfizer Recent Developments
    5.7 Novartis AG
        5.7.1 Novartis AG Profile
        5.7.2 Novartis AG Main Business
        5.7.3 Novartis AG Epilepsy Drugs Products, Services and Solutions
        5.7.4 Novartis AG Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.7.5 Novartis AG Recent Developments
    5.8 Abbvie
        5.8.1 Abbvie Profile
        5.8.2 Abbvie Main Business
        5.8.3 Abbvie Epilepsy Drugs Products, Services and Solutions
        5.8.4 Abbvie Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.8.5 Abbvie Recent Developments
    5.9 Janssen Pharmaceuticals
        5.9.1 Janssen Pharmaceuticals Profile
        5.9.2 Janssen Pharmaceuticals Main Business
        5.9.3 Janssen Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
        5.9.4 Janssen Pharmaceuticals Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.9.5 Janssen Pharmaceuticals Recent Developments
    5.10 Sunovion Pharmaceuticals
        5.10.1 Sunovion Pharmaceuticals Profile
        5.10.2 Sunovion Pharmaceuticals Main Business
        5.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
        5.10.4 Sunovion Pharmaceuticals Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.10.5 Sunovion Pharmaceuticals Recent Developments
    5.11 Bausch Health
        5.11.1 Bausch Health Profile
        5.11.2 Bausch Health Main Business
        5.11.3 Bausch Health Epilepsy Drugs Products, Services and Solutions
        5.11.4 Bausch Health Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.11.5 Bausch Health Recent Developments
    5.12 Sanofi S.A
        5.12.1 Sanofi S.A Profile
        5.12.2 Sanofi S.A Main Business
        5.12.3 Sanofi S.A Epilepsy Drugs Products, Services and Solutions
        5.12.4 Sanofi S.A Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.12.5 Sanofi S.A Recent Developments
    5.13 Takeda
        5.13.1 Takeda Profile
        5.13.2 Takeda Main Business
        5.13.3 Takeda Epilepsy Drugs Products, Services and Solutions
        5.13.4 Takeda Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.13.5 Takeda Recent Developments
    5.14 Eisai
        5.14.1 Eisai Profile
        5.14.2 Eisai Main Business
        5.14.3 Eisai Epilepsy Drugs Products, Services and Solutions
        5.14.4 Eisai Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.14.5 Eisai Recent Developments
    5.15 F. Hoffmann-La Roche
        5.15.1 F. Hoffmann-La Roche Profile
        5.15.2 F. Hoffmann-La Roche Main Business
        5.15.3 F. Hoffmann-La Roche Epilepsy Drugs Products, Services and Solutions
        5.15.4 F. Hoffmann-La Roche Epilepsy Drugs Revenue (US$ Million) & (2018-2023)
        5.15.5 F. Hoffmann-La Roche Recent Developments

 6 North America
    6.1 North America Epilepsy Drugs Market Size by Country (2018-2029)
    6.2 U.S.
    6.3 Canada

 7 Europe
    7.1 Europe Epilepsy Drugs Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Epilepsy Drugs Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Epilepsy Drugs Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Epilepsy Drugs Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Epilepsy Drugs Market Dynamics
    11.1 Epilepsy Drugs Industry Trends
    11.2 Epilepsy Drugs Market Drivers
    11.3 Epilepsy Drugs Market Challenges
    11.4 Epilepsy Drugs Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables
    Table 1. Global Market Epilepsy Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Epilepsy Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Epilepsy Drugs Market Size Share by Region (2018-2023)
    Table 4. Global Epilepsy Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Epilepsy Drugs Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Epilepsy Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Epilepsy Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Epilepsy Drugs Revenue Market Share by Type (2018-2023)
    Table 9. Global Epilepsy Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Epilepsy Drugs Revenue Market Share by Type (2024-2029)
    Table 11. North America Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Epilepsy Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Epilepsy Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Epilepsy Drugs Revenue Market Share by Application (2018-2023)
    Table 24. Global Epilepsy Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Epilepsy Drugs Revenue Market Share by Application (2024-2029)
    Table 26. North America Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Epilepsy Drugs Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Epilepsy Drugs Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2022)
    Table 39. Date of Key Players Enter into Epilepsy Drugs Market
    Table 40. Global Epilepsy Drugs Key Players Headquarters and Area Served
    Table 41. Epilepsy Drugs Product Solution and Service
    Table 42. Global Epilepsy Drugs Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Abbott Laboratories Basic Information List
    Table 45. Abbott Laboratories Description and Business Overview
    Table 46. Abbott Laboratories Epilepsy Drugs Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Epilepsy Drugs Business of Abbott Laboratories (2018-2023)
    Table 48. Abbott Laboratories Recent Developments
    Table 49. GlaxoSmithKline Plc Basic Information List
    Table 50. GlaxoSmithKline Plc Description and Business Overview
    Table 51. GlaxoSmithKline Plc Epilepsy Drugs Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Epilepsy Drugs Business of GlaxoSmithKline Plc (2018-2023)
    Table 53. GlaxoSmithKline Plc Recent Developments
    Table 54. UCB Basic Information List
    Table 55. UCB Description and Business Overview
    Table 56. UCB Epilepsy Drugs Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Epilepsy Drugs Business of UCB (2018-2023)
    Table 58. UCB Recent Developments
    Table 59. Cephalon Basic Information List
    Table 60. Cephalon Description and Business Overview
    Table 61. Cephalon Epilepsy Drugs Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Epilepsy Drugs Business of Cephalon (2018-2023)
    Table 63. Cephalon Recent Developments
    Table 64. Johnson & Johnson Basic Information List
    Table 65. Johnson & Johnson Description and Business Overview
    Table 66. Johnson & Johnson Epilepsy Drugs Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Epilepsy Drugs Business of Johnson & Johnson (2018-2023)
    Table 68. Johnson & Johnson Recent Developments
    Table 69. Pfizer Basic Information List
    Table 70. Pfizer Description and Business Overview
    Table 71. Pfizer Epilepsy Drugs Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Epilepsy Drugs Business of Pfizer (2018-2023)
    Table 73. Pfizer Recent Developments
    Table 74. Novartis AG Basic Information List
    Table 75. Novartis AG Description and Business Overview
    Table 76. Novartis AG Epilepsy Drugs Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Epilepsy Drugs Business of Novartis AG (2018-2023)
    Table 78. Novartis AG Recent Developments
    Table 79. Abbvie Basic Information List
    Table 80. Abbvie Description and Business Overview
    Table 81. Abbvie Epilepsy Drugs Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Epilepsy Drugs Business of Abbvie (2018-2023)
    Table 83. Abbvie Recent Developments
    Table 84. Janssen Pharmaceuticals Basic Information List
    Table 85. Janssen Pharmaceuticals Description and Business Overview
    Table 86. Janssen Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Epilepsy Drugs Business of Janssen Pharmaceuticals (2018-2023)
    Table 88. Janssen Pharmaceuticals Recent Developments
    Table 89. Sunovion Pharmaceuticals Basic Information List
    Table 90. Sunovion Pharmaceuticals Description and Business Overview
    Table 91. Sunovion Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Epilepsy Drugs Business of Sunovion Pharmaceuticals (2018-2023)
    Table 93. Sunovion Pharmaceuticals Recent Developments
    Table 94. Bausch Health Basic Information List
    Table 95. Bausch Health Description and Business Overview
    Table 96. Bausch Health Epilepsy Drugs Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Epilepsy Drugs Business of Bausch Health (2018-2023)
    Table 98. Bausch Health Recent Developments
    Table 99. Sanofi S.A Basic Information List
    Table 100. Sanofi S.A Description and Business Overview
    Table 101. Sanofi S.A Epilepsy Drugs Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Epilepsy Drugs Business of Sanofi S.A (2018-2023)
    Table 103. Sanofi S.A Recent Developments
    Table 104. Takeda Basic Information List
    Table 105. Takeda Description and Business Overview
    Table 106. Takeda Epilepsy Drugs Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Epilepsy Drugs Business of Takeda (2018-2023)
    Table 108. Takeda Recent Developments
    Table 109. Eisai Basic Information List
    Table 110. Eisai Description and Business Overview
    Table 111. Eisai Epilepsy Drugs Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Epilepsy Drugs Business of Eisai (2018-2023)
    Table 113. Eisai Recent Developments
    Table 114. F. Hoffmann-La Roche Basic Information List
    Table 115. F. Hoffmann-La Roche Description and Business Overview
    Table 116. F. Hoffmann-La Roche Epilepsy Drugs Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Epilepsy Drugs Business of F. Hoffmann-La Roche (2018-2023)
    Table 118. F. Hoffmann-La Roche Recent Developments
    Table 119. North America Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 120. North America Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 121. Europe Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 122. Europe Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 123. Asia-Pacific Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 124. Asia-Pacific Epilepsy Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 125. Asia-Pacific Epilepsy Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 126. Asia-Pacific Epilepsy Drugs Market Share by Region (2018-2023)
    Table 127. Asia-Pacific Epilepsy Drugs Market Share by Region (2024-2029)
    Table 128. Latin America Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 129. Latin America Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 130. Latin America Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 131. Middle East & Africa Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 132. Middle East & Africa Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 133. Middle East & Africa Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 134. Epilepsy Drugs Market Trends
    Table 135. Epilepsy Drugs Market Drivers
    Table 136. Epilepsy Drugs Market Challenges
    Table 137. Epilepsy Drugs Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epilepsy Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Epilepsy Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Epilepsy Drugs Market Share by Regions: 2022 VS 2029
    Figure 4. Global Epilepsy Drugs Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of First Generation
    Figure 11. Global First Generation Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Second Generation
    Figure 13. Global Second Generation Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Epilepsy Drugs Market Size Share by Type:  2022 & 2029
    Figure 15. North America Epilepsy Drugs Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Epilepsy Drugs Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Epilepsy Drugs Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Epilepsy Drugs Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Epilepsy Drugs Revenue Market Share by Type (2018-2029)
    Figure 20. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Global Epilepsy Drugs Market Size Share by Application: 2022 & 2029
    Figure 24. North America Epilepsy Drugs Revenue Market Share by Application (2018-2029)
    Figure 25. Europe Epilepsy Drugs Revenue Market Share by Application (2018-2029)
    Figure 26. Asia-Pacific Epilepsy Drugs Revenue Market Share by Application (2018-2029)
    Figure 27. Latin America Epilepsy Drugs Revenue Market Share by Application (2018-2029)
    Figure 28. Middle East and Africa Epilepsy Drugs Revenue Market Share by Application (2018-2029)
    Figure 29. Epilepsy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Top 5 and Top 10 Players Epilepsy Drugs Market Share in 2022
    Figure 31. North America Epilepsy Drugs Market Share by Country (2018-2029)
    Figure 32. U.S. Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 33. Canada Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 34. Germany Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 35. France Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 36. U.K. Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 37. Italy Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 38. Russia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 39. Nordic Countries Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Epilepsy Drugs Market Share by Region (2018-2029)
    Figure 41. China Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 42. Japan Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 43. South Korea Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 45. India Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 46. Australia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 47. Latin America Epilepsy Drugs Market Share by Country (2018-2029)
    Figure 48. Mexico Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 49. Brazil Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Epilepsy Drugs Market Share by Country (2018-2029)
    Figure 51. Turkey Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 53. UAE Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
    Figure 54. Bottom-up and Top-down Approaches for This Report

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

Epilepsy Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Epilepsy Drugs market is projected to reach US$ 5842.4 million in 2029, increasing from US$ 4769.1 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.

In terms of geography, the Americas led the global epilepsy drugs market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Abbott Laboratories
    GlaxoSmithKline Plc
    UCB
    Cephalon
    Johnson & Johnson
    Pfizer
    Novartis AG
    Abbvie
    Janssen Pharmaceuticals
    Sunovion Pharmaceuticals
    Bausch Health
    Sanofi S.A
    Takeda
    Eisai
    F. Hoffmann-La Roche

Segment by Type
    First Generation
    Second Generation

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Epilepsy Drugs market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Epilepsy Drugs introduction, etc. Epilepsy Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Epilepsy Drugs market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.